Joshua Harris is a Senior Vice President with responsibility for assessing and underwriting legal risk, focusing on patent and intellectual property matters. In this video, he explains the litigation trends to watch for in the pharma and biotech sectors:
- The emergence of patent-related litigation due to the enactment of both the America Invents Act and the BPCIA
- Big Pharma's inclinations to move towards more formal affirmative recovery programs
- Key ways in which pharma and biotech companies are monetizing their patent assets
This video was recorded in October 2022.
This communication shall not constitute an offer to sell or the solicitation of an offer to buy any ordinary shares or other securities of Burford. This video may not be copied, distributed, published or reproduced, in whole or in part.
